Squalene Market Predicted to Hit 8 Million by 2027| MarketsandMarkets™

Posted by Jack Martin on June 19th, 2023

The squalene market is estimated to grow to USD 198 million by 2027 from USD 143 million in 2022, at a CAGR of 6.8% between 2022 and 2027. Growth in R&D activities in the pharmaceuticals industry and rising popularity in nutraceuticals is expected to support the growth of the squalene market. However, consumer skepticism about animal-sourced products and limitations on shark fishing is restraining the growth of the market. On the other hand, new renewable sources for production have created opportunities for manufacturers. 

Amyris, Inc (US), SOPHIM (France), Merck KGaA (Germany), Kishimoto Special Liver Oil Co., Ltd. (Japan), Empresa Figueirense De Pesca (Portugal), Arbee (India), Oleicfat S.L. (Spain), NZ Green Health Ltd. (New Zealand), Otto Chemie Pvt. Ltd. (India) and Cibus (US), among others are the major players in this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=542345 

Amyris, Inc. is a biotechnology company that manufactures and commercializes consumer products and ingredients such as clean beauty, personal care, and health & wellness consumer products. The company also sells sustainable ingredients to sector leaders that serve flavor & fragrance (F&F), nutrition, food & beverage, and clean beauty & personal care end markets. The common stock of the company is traded on the NASDAQ Global Select Market under the symbol AMRS. The company operates its business into three segments: renewable products, licenses and royalties, and collaborations, grants and other. The company offers squalene through the renewable products segment.

• In August 2021, Amyris, Inc. launched Rose Inc., a clean color cosmetics brand. The products’ non-comedogenic formulas are developed with proprietary bioengineered and sustainably-sourced ingredients, including squalene and hemisqualane.
• In March 2020, Amyris, Inc. expanded its business by increasing the product efficiency of its cannabidiol (CBD) from 10% to 40%. The company uses sugarcane squalene (Neossance Squalane) as a carrier oil for cannabidiol (CBD) into the human skin.
• In August 2021, Amyris, Inc. launched the Terasana Clinical, a clean skincare brand. The products of this brand have a patented formulation that combines two of Amyris, Inc.s sustainably sourced ingredients, squalane and cannabigerol (CBG).
• In April 2020, Amyris, Inc. launched the squalene-based hand sanitizer named Pipette under its No Compromise Pipette baby care branded products. The hand sanitizer contains 65% USP plant-based ethyl alcohol, glycerin, and Amyris, Inc.’s sugarcane-derived squalene (for moisturizing benefit).

SOPHIM is a company specializing in the manufacturing of natural ingredients for the cosmetics industry. The core business of the company is based on the expertise of innovative distillation, esterification, and hydrogenation processes. The company has divided its product portfolio into four categories: natural emollients such as squalene & silicone alternatives, texture agents, fixing agents, and vegetable oils in cosmetics.

• In September 2021, SOPHIM launched a natural emollient named Sugar Squalane, which is produced from sugarcane via sucrose fermentation. A process of fermentation, distillation, dimerization, and hydrogenation transforms this sesquiterpene, into sugar squalane.
• In May 2021, SOPHIM launched a natural emollient named Phytosqualan, which is a high-quality vegetable squalane produced from unsaponifiable fraction of olive oil fatty acids and has applications in cosmetics such as face creams, dry oils for body care, makeup, and sun care.
• In January 2021, SOPHIM launched a moisturizing hand sanitizer that contains 2% Phytosqualan, which moisturizes the epidermis and helps make the superficial layers of the skin softer, smoother, and more supple.